Please login to the form below

Emma Walmsley

This page shows the latest Emma Walmsley news and features for those working in and with pharma, biotech and healthcare.

GlaxoSmithKline reportedly looking to sell select antibiotic brands

On a conference call last month, GSK CEO Emma Walmsley said that the company’s “first priority remains… to invest in R&D and future growth drivers”. ... Since the beginning of 2019, GSK and new CEO Walmsley have been trying to reverse that deal

Latest news

GSK considers more divestments to help R&D push

GSK’s chief executive Emma Walmsley (pictured right) reiterated yesterday on a conference call that GSK’s “first priority remains… to invest in R&D and future growth drivers”, adding that
FDA fast-tracks GSK’s anti-BCMA drug for multiple myeloma

ago. GSK’s new CEO Emma Walmsley (pictured left) and new R&D chief Hal Barron have helmed the company’s re-entry into oncology, having overseen a number of new
GSK divests travel vaccines to Bavarian Nordic as part of strategic refocus

The move follows a major ongoing strategy refocus at the British pharma, after CEO Emma Walmsley (pictured left) spearheaded plans to reinvest in the company’s oncology business at the beginning
GSK boosts outlook thanks to strong respiratory and vaccine sales

GSK has made further good progress in Q3, with sales growth across all three businesses, and we have today upgraded our full-year EPS guidance,” said Emma Walmsley (pictured left),
GSK hires Merck KGaA exec to lead US pharma business

On the surface, his replacement is a good fit for the new direction GSK is taking under the leadership of CEO Emma Walmsley and CSO Hal Barron. ... At GSK, Martinez-Davis will oversee US pharmaceuticals across all diseases but, if pipeline programmes

More from news
Approximately 2 fully matching, plus 47 partially matching documents found.

Latest Intelligence

Women Leaders in UK Healthcare: Liz Henderson

It’s also great to see outside Merck that women are also progressing in other companies too – like Emma Walmsley at GSK – which gives women the inspiration that they too can
25 Women Leaders in UK Healthcare

10. THEODORA HAROLD . Biotech leader. While big pharma is making some significant strides in having women as their top leaders (most notably GSK’s CEO Emma Walmsley), the biotech sector, particularly
Diversity and inclusion in the pharma industry

If, as GlaxoSmithKline CEO Emma Walmsley said, talking about diversity to Business Insider UK, ‘‘You cannot be a modern employer in an industry that should be future facing and modernising arguably
30 Women Leaders in UK Healthcare (part 3)

29. Emma Walmsley, GSK CEO. Emma Walmsley is the first-ever woman leader of a big pharma company, having taken on the CEO role at GlaxoSmithKline in April 2017. ... Since then, Walmsley has very definitely put her own stamp on the firm, making major
Pharma deals continue to slide

Emma Walmsley, CEO of GSK, said: “We will use cash for business development purposes, with M&A obviously dependent on the right kind of return profile.”.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

GSK appoints president of global pharmaceuticals

Emma Walmsley, GSK's chief executive officer designate, said: “Luke brings a combination of excellent R&D insight and a strong track record of commercial execution.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

Surviving cancer: a new era for patients: Now more than ever, a shift in perspective is needed...
Crisis? No problem!: Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?: First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....